Loading…

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone

BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the d...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2012-04, Vol.165 (8), p.2549-2560
Main Authors: Olango, WM, Roche, M, Ford, GK, Harhen, B, Finn, DP
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273
cites cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273
container_end_page 2560
container_issue 8
container_start_page 2549
container_title British journal of pharmacology
container_volume 165
creator Olango, WM
Roche, M
Ford, GK
Harhen, B
Finn, DP
description BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats. EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone. KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG. CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts. LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7
doi_str_mv 10.1111/j.1476-5381.2011.01478.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3407666471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</originalsourceid><addsrcrecordid>eNqNUUuO1DAQjRCIaQaugCyxTrCdOIkXIMEIGKSRYDGsrYpd6XErbQfbPXTvOAIX4VKcBIeeacEOb1yl9-rV5xUFYbRi-b3cVKzp2lLUPas4ZayiOe-r_YNidQIeFitKaVcy1vdnxZMYN3RhdeJxccaZaBva81Xx8_oGCTrjNTgHg3XeGhIPMeGWWEdSRgMkYnyIfoKEASYyY7DwdYdmp1NO1wEPZIvGZjiSESH8-v5De2dsst6hIeBgWmO0kCNDMpKCn45Mgvs5YIyZeN9uydFpJH4kzmurcU72FknKWk-LRyNMEZ_d_efFl_fvri8uy6tPHz5evLkqtaCsL0dtoAEKRiIfGAeQppVS6tYggxFxNIJLxrgeGiM62st2qMEYraUQIHlXnxevj7rzbsibacwjw6TmYLcQDsqDVf8izt6otb9VdcNrXoss8OJOIPh8qZjUxu9CvkNUTIimkV3Dm8zqjywdfIwBx1MHRtVitNqoxU-1-KkWo9Ufo9U-lz7_e8JT4b2zmfDqSPhmJzz8t7B6-_lyierfa2m_RA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554497424</pqid></control><display><type>article</type><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><source>Wiley</source><source>PubMed Central</source><creator>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</creator><creatorcontrib>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</creatorcontrib><description>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats. EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone. KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG. CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts. LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.2011.01478.x</identifier><identifier>PMID: 21564082</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Analgesia ; Animals ; Behavior ; Cannabinoid Receptor Modulators - physiology ; cannabinoid type 1 (CB1) receptor ; Conditioning (Psychology) - physiology ; Endocannabinoids ; fear ; Fear - drug effects ; Fear - physiology ; Formaldehyde ; Male ; Motor Activity - drug effects ; N‐acylethanolamines ; pain ; Pain - chemically induced ; Pain - physiopathology ; Periaqueductal Gray - drug effects ; Periaqueductal Gray - physiology ; periaqueductal grey ; Piperidines - pharmacology ; Pyrazoles - pharmacology ; Rats ; Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors ; Receptor, Cannabinoid, CB1 - physiology ; Rodents ; Themed Section: Research Papers ; Ultrasonics</subject><ispartof>British journal of pharmacology, 2012-04, Vol.165 (8), p.2549-2560</ispartof><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society</rights><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.</rights><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</citedby><cites>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21564082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olango, WM</creatorcontrib><creatorcontrib>Roche, M</creatorcontrib><creatorcontrib>Ford, GK</creatorcontrib><creatorcontrib>Harhen, B</creatorcontrib><creatorcontrib>Finn, DP</creatorcontrib><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats. EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone. KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG. CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts. LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</description><subject>Analgesia</subject><subject>Animals</subject><subject>Behavior</subject><subject>Cannabinoid Receptor Modulators - physiology</subject><subject>cannabinoid type 1 (CB1) receptor</subject><subject>Conditioning (Psychology) - physiology</subject><subject>Endocannabinoids</subject><subject>fear</subject><subject>Fear - drug effects</subject><subject>Fear - physiology</subject><subject>Formaldehyde</subject><subject>Male</subject><subject>Motor Activity - drug effects</subject><subject>N‐acylethanolamines</subject><subject>pain</subject><subject>Pain - chemically induced</subject><subject>Pain - physiopathology</subject><subject>Periaqueductal Gray - drug effects</subject><subject>Periaqueductal Gray - physiology</subject><subject>periaqueductal grey</subject><subject>Piperidines - pharmacology</subject><subject>Pyrazoles - pharmacology</subject><subject>Rats</subject><subject>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - physiology</subject><subject>Rodents</subject><subject>Themed Section: Research Papers</subject><subject>Ultrasonics</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNUUuO1DAQjRCIaQaugCyxTrCdOIkXIMEIGKSRYDGsrYpd6XErbQfbPXTvOAIX4VKcBIeeacEOb1yl9-rV5xUFYbRi-b3cVKzp2lLUPas4ZayiOe-r_YNidQIeFitKaVcy1vdnxZMYN3RhdeJxccaZaBva81Xx8_oGCTrjNTgHg3XeGhIPMeGWWEdSRgMkYnyIfoKEASYyY7DwdYdmp1NO1wEPZIvGZjiSESH8-v5De2dsst6hIeBgWmO0kCNDMpKCn45Mgvs5YIyZeN9uydFpJH4kzmurcU72FknKWk-LRyNMEZ_d_efFl_fvri8uy6tPHz5evLkqtaCsL0dtoAEKRiIfGAeQppVS6tYggxFxNIJLxrgeGiM62st2qMEYraUQIHlXnxevj7rzbsibacwjw6TmYLcQDsqDVf8izt6otb9VdcNrXoss8OJOIPh8qZjUxu9CvkNUTIimkV3Dm8zqjywdfIwBx1MHRtVitNqoxU-1-KkWo9Ufo9U-lz7_e8JT4b2zmfDqSPhmJzz8t7B6-_lyierfa2m_RA</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Olango, WM</creator><creator>Roche, M</creator><creator>Ford, GK</creator><creator>Harhen, B</creator><creator>Finn, DP</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>201204</creationdate><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><author>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analgesia</topic><topic>Animals</topic><topic>Behavior</topic><topic>Cannabinoid Receptor Modulators - physiology</topic><topic>cannabinoid type 1 (CB1) receptor</topic><topic>Conditioning (Psychology) - physiology</topic><topic>Endocannabinoids</topic><topic>fear</topic><topic>Fear - drug effects</topic><topic>Fear - physiology</topic><topic>Formaldehyde</topic><topic>Male</topic><topic>Motor Activity - drug effects</topic><topic>N‐acylethanolamines</topic><topic>pain</topic><topic>Pain - chemically induced</topic><topic>Pain - physiopathology</topic><topic>Periaqueductal Gray - drug effects</topic><topic>Periaqueductal Gray - physiology</topic><topic>periaqueductal grey</topic><topic>Piperidines - pharmacology</topic><topic>Pyrazoles - pharmacology</topic><topic>Rats</topic><topic>Receptor, Cannabinoid, CB1 - antagonists &amp; inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - physiology</topic><topic>Rodents</topic><topic>Themed Section: Research Papers</topic><topic>Ultrasonics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olango, WM</creatorcontrib><creatorcontrib>Roche, M</creatorcontrib><creatorcontrib>Ford, GK</creatorcontrib><creatorcontrib>Harhen, B</creatorcontrib><creatorcontrib>Finn, DP</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olango, WM</au><au>Roche, M</au><au>Ford, GK</au><au>Harhen, B</au><au>Finn, DP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2012-04</date><risdate>2012</risdate><volume>165</volume><issue>8</issue><spage>2549</spage><epage>2560</epage><pages>2549-2560</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats. EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone. KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG. CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts. LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21564082</pmid><doi>10.1111/j.1476-5381.2011.01478.x</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2012-04, Vol.165 (8), p.2549-2560
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423235
source Wiley; PubMed Central
subjects Analgesia
Animals
Behavior
Cannabinoid Receptor Modulators - physiology
cannabinoid type 1 (CB1) receptor
Conditioning (Psychology) - physiology
Endocannabinoids
fear
Fear - drug effects
Fear - physiology
Formaldehyde
Male
Motor Activity - drug effects
N‐acylethanolamines
pain
Pain - chemically induced
Pain - physiopathology
Periaqueductal Gray - drug effects
Periaqueductal Gray - physiology
periaqueductal grey
Piperidines - pharmacology
Pyrazoles - pharmacology
Rats
Receptor, Cannabinoid, CB1 - antagonists & inhibitors
Receptor, Cannabinoid, CB1 - physiology
Rodents
Themed Section: Research Papers
Ultrasonics
title The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A18%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20endocannabinoid%20system%20in%20the%20rat%20dorsolateral%20periaqueductal%20grey%20mediates%20fear%E2%80%90conditioned%20analgesia%20and%20controls%20fear%20expression%20in%20the%20presence%20of%20nociceptive%20tone&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Olango,%20WM&rft.date=2012-04&rft.volume=165&rft.issue=8&rft.spage=2549&rft.epage=2560&rft.pages=2549-2560&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/j.1476-5381.2011.01478.x&rft_dat=%3Cproquest_pubme%3E3407666471%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1554497424&rft_id=info:pmid/21564082&rfr_iscdi=true